Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Aterina

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/03/2026 Alfasigma
    Italy
    		 Sam-O Pharmaceutical Co., Ltd. 20121026-149-I-108-01 Sulrodexide 2012-10-26 Alfasigma SpA/@OPOCRIN SpA_x000D_ @(Sam-O Pharmaceutical Co., Ltd.) Italy Via Enrico Fermi 1-65020 Alanno (PE), Italy@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy_x000D_ @(135-925)7F, Sam-O Building, 151 Yeoksam-ro, Gangnam-gu, Seoul _x000D_
    31/03/2026 Alfasigma
    Italy
    		 Ajoo Pharmaceutical Co., Ltd. 20121026-149-I-108-01(1) Sulrodexide 2013-01-31 Alfasigma SpA@ OPOCRIN SpA Italy Via ENRICO FERMI 1-65020 ALANNO(PE), ITALY@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.